Benzinga - Tue, 02 Mar 2021 09:15:42 -0400
Benzinga - Mon, 01 Mar 2021 09:04:36 -0400
Benzinga - Thu, 18 Feb 2021 09:54:33 -0400
Benzinga - Wed, 10 Feb 2021 18:28:06 -0400
Benzinga - Thu, 04 Feb 2021 08:21:57 -0400
Benzinga - Wed, 03 Feb 2021 17:01:29 -0400
Benzinga - Wed, 27 Jan 2021 11:35:11 -0400
Benzinga - Wed, 27 Jan 2021 08:35:59 -0400
Benzinga - Tue, 26 Jan 2021 11:35:24 -0400
Benzinga - Tue, 26 Jan 2021 11:10:59 -0400
Benzinga - Tue, 26 Jan 2021 09:35:09 -0400
Benzinga - Tue, 26 Jan 2021 09:07:39 -0400
Benzinga - Tue, 26 Jan 2021 08:10:46 -0400
Benzinga - Tue, 26 Jan 2021 08:09:57 -0400
Benzinga - Tue, 26 Jan 2021 08:09:28 -0400
load more
Sector: Health Care.Industry: Biotechnology
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-03
REV
Q4 2020Est.ActualSurprise
EPS-0.800-0.790 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RYTMRhythm Pharmaceuticals1.88%1.3B

Rhythm Pharmaceuticals Company Questions & Answers

Q

How do I buy Rhythm Pharmaceuticals (RYTM) stock?

A

You can purchase shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rhythm Pharmaceuticals's (RYTM) main competitors?

A

Other companies in Rhythm Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), 4D Molecular Therapeutics (NASDAQ:FDMT) and Protagonist Therapeutics (NASDAQ:PTGX).

Q

What is the target price for Rhythm Pharmaceuticals?

A

The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Morgan Stanley on 2021-03-02. The analyst firm set a price target for 57.00 expecting RYTM to rise to within 12 months (a possible 119.40% upside). 9 analyst firms have reported ratings in the last year.

Q

How much is Rhythm Pharmaceuticals (RYTM) stock ?

A

The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $25.98 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Rhythm Pharmaceuticals (RYTM) dividend?

A

There are no upcoming dividends for Rhythm Pharmaceuticals.

Q

When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?

A
Rhythm Pharmaceuticals’s Q1 earnings are confirmed after-market from now on May 3, 2021.
Q

When is the upcoming split for RYTM?

A

There is no upcoming split for Rhythm Pharmaceuticals.